Tolerance and efficacy of early nicotine substitution after acute coronary syndromes;Tolérance et efficacité de la substitution nicotinique précoce au décours d'un syndrome coronaire aigu

Archives des Maladies du Coeur et des Vaisseaux

Volumn 100, Issue 6-7, 2007, Pages 514-518

  Guevel Jointret, A L ^a   Borel, M L ^a   Munier, S ^a   Cornily, J C ^a   Pennec, P Y ^a   Gilard, M ^a   Mansourati, J ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINE;

ARTICLE; CARDIOVASCULAR RISK; HEART INFARCTION; HEART MUSCLE ISCHEMIA; RISK FACTOR;

ANGINA PECTORIS, VARIANT; ANGINA, UNSTABLE; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NICOTINIC AGONISTS; PATIENT EDUCATION; QUESTIONNAIRES; RECURRENCE; RETROSPECTIVE STUDIES; SMOKING; SMOKING CESSATION; STENTS;

EID: 34547755641     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study) : case-control study. Lancet 2004 ; 364 : 937-52.
2. Ezzati M, Henley SJ, Thun MJ, Lopez AD. Role of smoking in global and regional cardiovascular mortality. Circulation 2005 ; 112 : 489-97.
3. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease. An update. J Am Coll Cardiol 2004 ; 43 : 1731-7.
4. Hill C, Laplanche A. Evolution du tabagisme en France par sexe, 1990-2003. BEH 2005 no 21-22 : 94-7.
5. Van Berkel TFM, Boersma H, Roos-Hesselink JW, Erdman RAM, Simoons ML. Impact of smoking cessation and smoking interventions in patients with coronary artery disease. Eur Heart J 1999 ; 20 1773-82.
6. Scholte op Reimer, de Swart E, De Bacquer D, et al. for the EUROASPIRE investigators. Smoking behaviour in European patients with established coronary heart disease. Eur Heart J 2006 ; 27 : 35-41.
7. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking : toward an integrative model of change. J Consult Clin Psychol 1983 ; 51 : 390-5.
8. Borgne A. Sevrage tabagique : conduite pratique. Arch Mal Cœur Vaiss 2002 ; 95 : 799-803.
9. Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994 ; 343 : 139-42.
10. Danchin N, Grenier O, Ferrieres J, Cambou JP. Secondary prevention of patients with acute coronary syndrome in France : results of the PREVENIR survey. Ann Cardiol Angeol 2002 ; 51 : 15-9.
11. AFSSAPS (Agence Française de Sécurité Sanitaire des Produits de Santé). Les stratégies thérapeutiques médicamenteuses et non médicamenteuses de l'aide à l'arrêt du tabac. Recommandation de bonne pratique. Mai 2003. (http://afssaps.sante.fr/htm/10/tabac/sommaire.htm)
12. Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996 ; 335 : 1792-8.
13. Tzivoni D, Keren A, Meyler S, Khoury Z, Lerer T, Brunel P. Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovasc Drugs Ther 1998 ; 12 : 239-44.
14. Mahmarian JJ, Moyé LA, Nasser GA, et al. Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol 1997 ; 30 : 125-30.
15. Nitenberg A, Antony I. Effects of nicotine gum on coronary vasomotor responses during sympathetic stimulation in patients with coronary artery stenosis. J Cardiovasc Pharmacol 1999 ; 34 : 694-9.
16. Zevin S, Jacob P, Benowitz NL. Dose-related cardiovascular and endocrine effects of transdermal nicotine. Clin Pharmacol Ther 1998 ; 64 : 87-95.
17. Adams KF, Koch G, Chatterjee B, et al. Acute elevation of blood carboxyhemoglobin to 6 % impairs exercise performance and aggravates symptoms in patients with ischemic heart disease. J Am Coll Cardiol 1988 ; 12 : 900-9.
18. Aubin HJ, Tilikete S, Lahmek P. Traitement cognitivo- comportemental du tabagisme. Alcoologie et Addictologie 2000 ; 22 : 313-8.
19. Meine TJ, Patel MR, Washam JB, Pappas PA, Jollis JG. Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am J Cardiol 2005 ; 95 : 976-8.